Merit Medical Systems, Inc. (MMSI) vs Travere Therapeutics, Inc. (TVTX)

A side-by-side comparison of Merit Medical Systems, Inc. and Travere Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MMSI vs TVTX

growth of $100 · dividends reinvested · last 10y
MMSI +260.8% (+13.7%/yr)TVTX +150.2% (+9.6%/yr)MMSI compounded faster over this window
0100200300400Start $10020182020202220242026$361$250
MMSI TVTX

MMSI vs TVTX: by the numbers

  • •TVTX is the larger company ($5.21B vs $5.07B market cap).
  • •MMSI is profitable (9.22% net margin) while TVTX runs a net loss (-7.35%).
  • •TVTX grew revenue faster over the past five years (23.71% vs 8.90% CAGR).

Metrics side by side

Valuation

MetricMMSITVTX
P/E ratio35.11N/A
Forward P/E19.75N/A
P/S ratio3.218.80
P/B ratio3.02212.29
EV / EBITDA16.14248.98
FCF yield4.01%0.99%

Profitability

MetricMMSITVTX
Gross margin49.52%94.41%
Operating margin12.75%-6.84%
Net margin9.22%-7.35%
ROE8.67%-177.24%
ROIC5.80%-6.19%

Growth (annualized)

MetricMMSITVTX
Revenue CAGR (5Y)8.90%23.71%
FCF CAGR (5Y)8.96%N/A
Total return CAGR (5Y)3.88%17.83%

Frequently asked

Which has grown faster, MMSI or TVTX?
Over the past five years, TVTX grew revenue faster — MMSI at a 8.90% CAGR versus TVTX at 23.71%.
Is MMSI or TVTX more profitable?
MMSI runs the higher net margin — MMSI at 9.22% versus TVTX at -7.35%.
How have MMSI and TVTX total returns compared?
Over the past 10 years, MMSI delivered 13.48% and TVTX delivered 9.57% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.